Sean Kim
Stock Analyst at JonesTrading
(0.47)
# 3,946
Out of 4,843 analysts
8
Total ratings
33.33%
Success rate
-14.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Kim
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DRRX DURECT | Downgrades: Hold | n/a | $0.53 | - | 2 | Nov 9, 2023 | |
| ARQT Arcutis Biotherapeutics | Downgrades: Hold | n/a | $13.04 | - | 2 | Nov 8, 2023 | |
| CLSD Clearside Biomedical | Initiates: Buy | $6 | $0.76 | +688.44% | 1 | Jun 14, 2023 | |
| OVID Ovid Therapeutics | Initiates: Buy | $6 | $0.27 | +2,104.26% | 1 | Jun 14, 2023 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Buy | $26 | $7.24 | +259.12% | 1 | Jun 14, 2023 | |
| TRVI Trevi Therapeutics | Initiates: Buy | $7 | $6.51 | +7.53% | 1 | Mar 14, 2023 |
DURECT
Nov 9, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.53
Upside: -
Arcutis Biotherapeutics
Nov 8, 2023
Downgrades: Hold
Price Target: n/a
Current: $13.04
Upside: -
Clearside Biomedical
Jun 14, 2023
Initiates: Buy
Price Target: $6
Current: $0.76
Upside: +688.44%
Ovid Therapeutics
Jun 14, 2023
Initiates: Buy
Price Target: $6
Current: $0.27
Upside: +2,104.26%
EyePoint Pharmaceuticals
Jun 14, 2023
Initiates: Buy
Price Target: $26
Current: $7.24
Upside: +259.12%
Trevi Therapeutics
Mar 14, 2023
Initiates: Buy
Price Target: $7
Current: $6.51
Upside: +7.53%